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Post operativeAbstract Eccrine porocarcinoma is a rare malignant sweat gland tumor arising from the intra der-
mal part of the gland and accounts for only 0.005% of all epithelial cutaneous tumors. Commonly
involved site includes extremities and face. Scalp is a rare site for porocarcinoma with less than 20
reported cases so far. Wide local excision with clear margins remains the treatment of choice.
Review of literature revealed a local recurrence rate of 37.5% and a nodal involvement risk of
20%. Porocarcinoma of the scalp is peculiar in that the primary tumor may be large at presentation,
making surgery with adequate margins difficult. Adjuvant radiotherapy must be considered in a
case to case basis due to the high local recurrence rates compared to other sites of porocarcinoma
and should be given to all patients with close margins and extra capsular extension.
 2016 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Eccrine porocarcinoma is a rare malignant adnexal tumor aris-
ing from the intra dermal part of the sweat gland accounting
for 0.005% of all epithelial cutaneous tumors. It is the malig-
nant counterpart of common benign adnexal tumor (eccrine
poroma) and is also termed as malignant hidroacanthoma sim-
plex/eccrine poroepithelioma/malignant syringoacanthoma/
dysplastic poroma. Eccrine porocarcinoma may arise de novo
or as the malignant transformation of long standing benignporoma. Commonly involved site is lower extremity, though
it has also been reported to arise from upper extremities, scalp
and face also. Local recurrences and lymph node metastasis
are seen in 20% of cases. Wide local excision with clear mar-
gins is the treatment of choice. The role of adjuvant radiother-
apy has not been well defined. Scalp is a rare site for
porocarcinoma with less than 20 reported cases. Here we pre-
sent a case of porocarcinoma of the scalp treated with adjuvant
radiotherapy and a literature review of cases of scalp porocar-
cinoma to evaluate the appropriate treatment in such cases.
Case report
A 42 year old male, without co-morbidities, presented with
recurrent ulcer over the occipital region of scalp since 2011.
Local examination revealed a 5 * 4 * 3 cm fungating ulcer pre-
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systemic examination were normal. Magnetic resonance imag-
ing (MRI) of brain showed a well marginated lesion in sub-
galeal soft tissue of the right occipital region with preserved
occipital bone (Fig. 1). The lesion was hypo intense in T1
and T2 sequences and showed contrast enhancement. There
was no intracranial extension or regional lymph nodal enlarge-
ment in MRI. Biopsy of the lesion was suggestive of eccrine
poroma.
He underwent wide local excision with 1 cm margin all
around. Post-operative histopathology revealed a tumor of size
4.5 * 3.5 * 1.5 cm and was suggestive of eccrine porocarcinoma
with involved deep resected margin. The tumor cells showed
nuclear pleomorphism, calcification, necrosis and occasional
duct like structure lined by cuticular cells (Fig. 2). The pho-
tomicrograph showing patient was re-evaluated with contrast
enhanced computed tomography which showed plaque like
soft tissue thickening in the occipital region with thinning of
occipital bone. There were multiple enlarged lymph nodes in
the right posterior cervical region (largest 1.4 cm in short axis
diameter). Fine needle aspiration cytology from cervical lymph
node showed metastatic deposits from an adnexal tumor. The
patient again underwent wide local excision with 1 cm margin
all around with posterior neck node dissection. Histopatholog-
ically, it showed porocarcinoma in resected specimen with
metastasis to cervical lymph nodes with extra capsular exten-
sion. The tumor cells showed mild nuclear pleomorphism with
foci of calcification and necrosis. Atypical mitosis was also
seen. The deep resected margin was also involved by tumor.
In view of presence of positive margin and presence of extra
capsular extension in the nodal area, the patient was planned
for adjuvant radiotherapy. Radiotherapy to the occipital
region was planned with 12 MeV electrons and to neck by pho-
tons to a dose of 64 gray in conventional fractionation till. The
patient developed acute grade II mucositis, grade II dysphagia
and grade I dermatitis during treatment. Twelve months post
treatment, the patient remains free of disease in local and
nodal sites. The patient had chronic grade II xerostomia at
the last follow-up.Figure 1 Magnetic resonance imaging of the patient showing a wellDiscussion
Eccrine porocarcinoma are extremely rare malignant tumors
arising from the intra dermal part of sweat gland. It was first
described by Pinkus and Mehregan in 1963 [1]. Mishisma
and Moriko later introduced the term ‘‘eccrine porocarci-
noma” in 1969 [2]. Porocarcinoma occurs equally in both sexes
and predominantly in elderly. It presents as an ulcerated nod-
ule or plaque, in lower extremities (50%), trunk (24%) or head
and neck (24%). Prognosis is variable with wide local excision
showing curative results. Lymph node metastasis and distant
metastasis are associated with poorer prognosis. There are
many reports that this cancer may arise from eccrine poroma
and in our patient also it arose from a pre-existing poroma.
Bone involvement is rare in this tumor and in our case also
bone was free.
Microscopic appearance usually shows atypical tumor cells
arranged in cords and lobules which may involve both dermis
and epidermis. Tumor cell shows nuclear atypia with frequent
mitosis and necrosis. These findings were evident in our
patient. Robson et al. reported few histopathological factors
that are predictive for poorer clinical outcome and death.[3]
These are (1) presence of more than 14 mitosis per high power
field (2) lymphovascular invasion (3) tumor depth >7 mm (4)
infiltrating margins.
Wide excision or Mohs micrographic surgery is the treat-
ment of choice. Surgery alone has shown curative results in
70% of cases although a recurrence rate of 20% is seen. Regio-
nal lymph nodes should be assessed as porocarcinoma has
shown propensity to invade dermal lymphatics which cause
lymph nodal disease in about 20% of the cases.[4] In our
patient wide local excision was done with lymph node dissec-
tion in view of lymph node involvement.
A review of cases of porocarcinoma of the scalp in which
the clinical details were available is summarized in Table 1
[5–13]. Clinical summary of 10 patients could be retrieved.
The median age of diagnosis was 52 years. 40% of the cases
arose from a pre-existing poroma. The median tumor size
was 5 cm (range 0.4–8 cm). Bone involvement was not seenmarginated contrast enhancing lesion in the right occipital region.
Figure 2 Representative photomicrograph showing tumor cells with mild nuclear pleomorphism, calcification, necrosis and occasional
duct like structure lined by cuticular cells (H & E 200).
Table 1 A summary of cases of porocarcinoma of the scalp in which the clinical details were available.
Study Age Tumor size Bone
involvement
Node and
site
Surgery
type
Adjuvant
treatment
Survival
outcome
Recurrence Comments
Le [5] 84 No No Excision No 5 years No Sarcomatoid
porocarcinoma of
the scalp
Kim [6] 52 3.7  2.1 No No Excision Developed from
eccrine poroma
Permi [7] 35 5  4 No No Excision No 1.5 years No Developed from
eccrine poroma
Kose [8] 52 8 No No Excision No 1 year No Developed from
eccrine poroma.
Pt received
radiation therapy
for cervical cancer
Grimme [9] 47 1.5  1 No No Excision No 0.5 year Yes, local and
distant
Nodal, liver, kidney
and bone metastasis
Maguire [10] 58 0.4 No No Excision No Alive Local
Tarkhan [11] 45 7  5 No Yes,
intra-
parotid
Excision No 8 months Local, regional
lymph node,
skin
Arise from
sebaceous nevus
Pal [12] 58 5  4  4 No No Excision 6 cycle
chemotherapy
1 year No
Ekmekci [13] 78 2.5  2  1.5 No Arise from recurrent
BCC
Present
report
45 5 * 4 * 3 No Yes,
posterior
cervical
Excision Adjuvant
radiotherapy
8 months No Developed from
eccrine poroma
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patients with scalp porocarcinoma and it is similar to the inci-
dence of lymph node metastasis in other sites of porocarci-
noma. The relatively big tumor size in scalp porocarcinoma
makes surgical resection with adequate margins difficult. The
high incidence of lymph nodal metastasis in these lesions war-
rants an elective lymph node dissection. Both patients who had
lymph metastasis had a primary tumor size of more than 5 cm,thus making it logical to undertake lymph node dissection in
patients with large tumor size.
Traditionally adjuvant treatment was not given in patients
with porocarcinoma. Out of ten patients one patient received
adjuvant chemotherapy and the patient in the present report
received adjuvant radiotherapy. In the eight patients who did
not receive adjuvant treatment the local recurrence rate was
37.5% (3 patients out of 8). The peculiar site of the tumor
198 W. Melgandi et al.and relatively large tumor size along with infiltrative nature of
the disease may be responsible for this high local recurrence
rates. Thus giving adjuvant radiotherapy may be logical in
these patients to reduce local recurrence, especially when mar-
gins are close. In our report adjuvant radiotherapy was used in
view of extra capsular extension in the lymph node and posi-
tive resected margin even after re-excision.
Chemotherapy is mainly reserved for metastatic disease.
But the response rate remains questionable [9]. Intra-lesional
photodynamic therapy has also been tried in some reports
but there is lack of convincing evidence to support its use rou-
tinely. Gonzalez et al. studied combined modality treatment
(surgery, oral isotretinoin and radiotherapy), and reported
excellent outcome with disease free survival of 5.6 years, in a
patient of metastatic eccrine porocarcinoma [14].
Primary surgery gives the best outcome in localized eccrine
porocarcinoma. The high chance of nodal involvement war-
rants evaluation of regional nodes, especially in patients with
large tumor size (more than 5 cm). Porocarcinoma of the scalp
is peculiar in that the tumor may be big at presentation, mak-
ing surgery with adequate margins difficult. The use of adju-
vant radiotherapy may be logical in view of high chance of
local recurrence in scalp porocarcinomas. Adjuvant radiother-
apy must be considered in a case to case basis and must be
done in all patients with close margins and extra capsular
extension.
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